Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer.
暂无分享，去创建一个
D. Gandara | E. Felip | L. Paz-Ares | R. Rosell | K. Danenberg | N. Viñolas | M. Taron | M. Sánchez-Ronco | B. Massuti | J. Sánchez | M. Provencio | C. Camps | V. Alberola | M. Dómine | J. Sánchez | M. Cobo | D. Isla | G. López-Vivanco | A. Montes | M. Muñoz | B. Massutí